Zoetis Stock News

Central Bank & Trust Co. increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 33.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,744 shares of the companys stock after acquiring an additional 5,501 shares during the quarter. []

The ZOE symptom-tracking study estimated that 80,483 people in the UK fell ill per day in the week ending November 27, based on test results from around 650,000 volunteers.

NEXT Financial Group Inc decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 10.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,791 shares of the companys stock after selling 457 shares during the period. NEXT Financial Group Incs holdings in Zoetis were []

HTF MI Analyst have added a new research study on Title Worldwide Pet Pharmaceuticals Market In-depth Research Report 2021, Forecast to 2026 with detailed information of Product Types [, Pet Pharmaceuticals markets by type, Antiparasitic, Biological Products, Antibacterial & Others],

This letter to a member of the United States Air Force went wildly viral on Reddit because it is comically brutal and hilariously straight to the point. ‘Got this letter from Zoe while deployed. She gets it,’ said Redditor TheDeepBlueZ Just in case it’s tricky to read … Dear United States Veteran Hello! I’m Zoe […] The post This girl’s letter to a member of the US Air Force is hilariously straight talking appeared first on The Poke .

Related Stocks: ZTS ,

Complete study of the global Screen Recording Software market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of

Complete study of the global Veterinary Insulin Drugs market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of

Bard Financial Services Inc. cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 8.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,580 shares of the companys stock after selling 325 shares during the period. Bard Financial Services Inc.s holdings []

Prominent companies in the animal health market include Elanco Animal Health, Bayer AG, Boehringer Ingelheim, Merck & Co., Inc., Zoetis, Inc., Dechra Pharmaceuticals, and Neogen Corporation. Prominent companies in the animal health market include Elanco Animal Health, Bayer AG, Boehringer Ingelheim, Merck & Co., Inc., Zoetis, Inc., Dechra Pharmaceuticals, and Neogen Corporation.

Zoetis Inc. found using ticker (ZTS) have now 13 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 240 and 184 calculating the mean target price we have 225. With the stocks previous close at 223.17 this now indicates there is a potential upside of .8%. The 50 day moving average now sits at 208.25 and the 200 day moving average is 187.13. The company has a market cap of $107,079m. Company Website: /> [stock_market_widget type="chart" symbol="ZTS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms.

When a company's return on equity (ROE) ratio is better than most of its competitors, it generally indicates that the company has been very efficient in generating profits. Thus, investors may want to

Lantz Financial LLC trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 13.7% in the 3rd quarter, Holdings Channel reports. The firm owned 1,283 shares of the companys stock after selling 204 shares during the period. Lantz Financial LLCs holdings in Zoetis were worth $249,000 at the end of the most recent reporting period. []

A NEW variant of coronavirus may supplant the current Delta variant, which has wreaked havoc across the world. The most pressing concern is that the variant may evade some of the immunity conferred from the vaccines. According to the ZOE COVID study app, there are two main coronavirus symptoms to watch out for if youre Continue reading Amid new Covid variant fears, there are two Covid symptoms in fully vaccinated to spot Amid new Covid variant fears, there are two Covid symptoms in fully vaccinated to spot

Manning & Napier Group LLC lessened its stake in Zoetis Inc. (NYSE:ZTS) by 2.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 226,808 shares of the company’s stock after selling 4,965 shares during the period. Manning & Napier Group LLC’s holdings in Zoetis […] The post Zoetis Inc. (NYSE:ZTS) Stock Position Cut by Manning & Napier Group LLC appeared first on ETF Daily News .